Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High-Throughput Screening of the Saccharomyces cerevisiae Genome for 2-Amino-3-Methylimidazo [4,5-f] Quinoline Resistance Identifies Colon Cancer-Associated Genes

ABSTRACT: High-Throughput Screening of the Saccharomyces cerevisiae Genome for 2-Amino-3-Methylimidazo [4,5-f] Quinoline Resistance Identifies Colon Cancer-Associated Genes

PROVIDER: PRJNA892968 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22007700.fastq.gz	Fastqsanger.gz
	SRR22007701.fastq.gz	Fastqsanger.gz
	SRR22007702.fastq.gz	Fastqsanger.gz
	SRR22007703.fastq.gz	Fastqsanger.gz
	SRR22007704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 80

Similar Datasets

High-Throughput Screening of the Saccharomyces cerevisiae Genome for 2-Amino-3-Methylimidazo [4,5-f] Quinoline Resistance Identifies Colon Cancer-Associated Genes

Project description:162 genes were identified as conferring resistance to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 334 genes were identified as conferring resistance to bioactivated IQ.

2023-01-01 | GSE216310 | GEO

A prospective study of amino acid profile index for colorectal cancer screening.

Project description:Interventions: amino index cancer screening test and fecal immunochemical test Primary outcome(s): Sensitivity of AICS for colorectal adenoma, intramucosal cancer and submucosal invasive cancer Study Design: Single arm Non-randomized

| 2642563 | ecrin-mdr-crc

Gene expression profiles in the colon epithelia of the humanized CYP1A (hCYP1A) mice treated with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

Project description:Gene expression profiles in the colon epithelia of the humanized CYP1A (hCYP1A) mice treated with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

| PRJNA695523 | ENA

denitrifying quinoline degrading microbial consortium

Project description:Draft Genome Sequence of Thauera sp. DTG from a denitrifying quinoline degrading microbial consortium

| PRJEB11730 | ENA

Proteomic analysis of normal colon epithelium

Project description:Normal colon epithelium biopsies were obtained from screening colonoscopies performed at Vanderbilt University IRB approval #061096. Sixty pinch biopsies were obtained from both ascending and descending colon from 30 subjects with completely normal findings during colonoscopy. Protein lysates were digested and fractionated using bRP-HPLC resulting in 15 fractions. RAW files and files searched using MS-GF+ are included (Zhang et al. Nature 2014; 513:382-7)

2015-03-28 | MSV000079088 | MassIVE

Transcriptomic profile indicative of immunotoxic exposure; in vitro studies in peripheral blood mononuclear cells

Project description:Investigating the immunotoxic effects of exposure to chemicals usually comprises evaluation of weight and histopathology of lymphoid tissues, various lymphocyte parameters in the circulation and immune function. Immunotoxicity assessment is time consuming in humans or requires a high number of animals, making it expensive. Furthermore, reducing the use of animals in research is an important ethical and political issue. Immunotoxicogenomics represents a novel approach to investigate immunotoxicity able of overcoming these limitations. The current research, embedded in the EU project NewGeneris, aimed to retrieve gene expression profiles that are indicative of exposure to immunotoxicants. To this end, whole genome gene expression was investigated in human peripheral blood mononuclear cells (PBMC) in response to in vitro exposure to a range of immunotoxic chemicals (4-hydroxy-2-nonenal, aflatoxin B1, benzo[a]pyrene, deoxynivalenol, ethanol, malondialdehyde, polychlorinated biphenyl 153, 2,3,7,8-tetrachlorodibenzo-p-dioxin) and non-immunotoxic chemicals (acrylamide, dimethylnitrosamine, 2-amino-3-methyl-3H-imidazo[4,5-F]quinoline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine). Using Agilent oligonucleotide microarrays, whole genome gene expression profiles were generated, which were analysed using Genedata’s Expressionist® software. Using Recursive Feature Elimination and Support Vector Machine, a set of 48 genes was identified that distinguishes the immunotoxic from the non-immunotoxic compounds. Analysis for enrichment of biological processes showed the gene set to be highly biologically and immunologically relevant. We conclude that we have identified a transcriptomic profile indicative of immunotoxic exposure. Keywords: Genome wide gene expression analysis, Transcriptomic profile indicative of immunotoxic exposure

2009-11-19 | GSE19078 | GEO

The Prostate, Lung, Colon, Ovary Screening Trial (PLCO): Etiologic and Early Marker Study

Project description:The Prostate, Lung, Colon, Ovary Screening Trial (PLCO): Etiologic and Early Marker Study

| PRJNA371285 | ENA

Transcription profiling of human lung adenocarcinoma A549 cells treated with vehicle (DMSO) or Etoposide (ETOP, 10 uM ), Benzo(a)pyrene Cryptolepineand 2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine for 6 h, 16 h, 24 h, 48 h and 72 h

Project description:Title: Prediction of cell cycle behaviour in response to DNA damage agents via transcriptomic approach <br/> Description: Human lung adenocarcinoma A549 cells were treated with vehicle (DMSO) or Etoposide (ETOP, 10 M-BM-5M ), Benzo(a)pyrene (BaP, 25 M-BM-5M ), Cryptolepine ( CLP, 2.5 M-BM-5M) and 2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP, 50 M-BM-5M) for 6 h, 16 h, 24 h, 48 h and 72 h.

2006-06-01 | E-MIMR-102 | biostudies-arrayexpress

High-throughput transcriptomics platform for screening hepatotoxicants

Project description:High-throughput transcriptomics platform for screening hepatotoxicants

| PRJNA638385 | ENA

ATAC-seq data in normal colon mucosa

Project description:This dataset includes ATAC-seq data generated in normal colon mucosa obtained in four healthy volunteers during colonoscopy indicated for colorectal cancer screening. Subjects had no lesions in the colon. Also includes one frozen sw480 colon adenocarcinoma cell line sample for piloting the protocol

| EGAS00001005281 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data